AI Medical Compendium Topic:
Urinary Bladder Neoplasms

Clear Filters Showing 361 to 370 of 385 articles

[A Case of Robot-Assisted Radical Cystoprostatectomy for Locally Advanced Prostate Cancer with Bladder Infiltration].

Hinyokika kiyo. Acta urologica Japonica
While robot-assisted radical cystoprostatectomy (RARC) for locally advanced prostate cancer (LAPC) may sometimes prove to be excessive treatment, it can significantly reduce the risk of positive surgical margins and lower urinary tract obstruction in...

[Clinical outcomes for young patients with muscular invasive bladder cancer who received robot-assisted radical cystectomy].

Zhonghua yi xue za zhi
To evaluate the clinical features, surgical effects and factors that may affect prognosis of muscular invasive bladder cancer in young people. The clinical data of young (aged 44 and below) patients with muscle invasive bladder cancer who underwent...

Simultaneous laparoscopic nephroureterectomy and robot-assisted anterior pelvic exenteration with intracorporeal ileal conduit urinary diversion: step-by-step video-illustrated technique.

International braz j urol : official journal of the Brazilian Society of Urology
INTRODUCTION:: One of the most remarkable characteristics of urothelial carcinomas is multifocality. However, occurrence of synchronous bladder cancer and upper urinary tract urothelial cancer (UTUC) is exceptional. Minimally invasive approach for th...

[Robot-assisted radical cystectomy with neobladder formation].

Urologiia (Moscow, Russia : 1999)
INTRODUCTION: Robot-assisted radical cystectomy (RARC) with intracorporeal neobladder formation is a complex surgical procedure.

Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence.

Current opinion in urology
PURPOSE OF REVIEW: Radical cystectomy is the definitive surgical treatment for aggressive bladder cancer. The robotic platform offers a new approach to radical cystectomy, but the benefits are unclear. This review examines the latest evidence, with a...

Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn in the last 24 months: a critical review.

Current opinion in urology
PURPOSE OF REVIEW: Patients with nonmuscle invasive bladder cancer (NMIBC) have a high risk of recurrent tumors, even in spite of contemporary guideline recommended therapy. Follow-up recommendations are also clear (cystoscopy with cytology and upper...